Literature DB >> 6206131

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

J Gerdes, H Lemke, H Baisch, H H Wacker, U Schwab, H Stein.   

Abstract

The monoclonal antibody Ki-67 detects a nuclear antigen that is present only in proliferating cells. The aim of the present investigation was to clarify whether the Ki-67 nuclear antigen is restricted in its expression to certain phases of the cell cycle. All experiments consistently showed that the Ki-67 nuclear antigen is present in S, G2, and M phase, but is absent in G0. However, the results concerning Ki-67 antigen expression in G1 phase varied: cells passing the early events of mitogen triggered transition from G0 to G1, i.e., G1T and first G1A, lacked the Ki-67 nuclear antigen, whereas G1 cells after mitosis were constantly Ki-67-positive. This result suggests that after mitosis cells might not follow the same metabolic pathways as G0 cells do when entering G1 for the first time. Therefore, we suggest that the early stages of mitogen stimulation represent initial sequences of proliferation and not parts of the cell cycle. Because our data show that the Ki-67 nuclear antigen is present throughout the cell cycle, immunostaining with monoclonal antibody Ki-67 provides a reliable means of rapidly evaluating the growth fraction of normal and neoplastic human cell populations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206131

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  1086 in total

1.  The T cell receptor repertoire of CD8+CD28- T lymphocytes is dominated by expanded clones that persist over time.

Authors:  E N Mugnaini; T Egeland; A Spurkland; J E Brinchmann
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 2.  Pigmented human skin equivalent--as a model of the mechanisms of control of cell-cell and cell-matrix interactions.

Authors:  K Nakazawa; M Kalassy; F Sahuc; C Collombel; O Damour
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

3.  Synchronous ileal autotransplantation impairs adaptation of remaining gut in pigs with proximal small bowel resection.

Authors:  J Lauronen; M P Pakarinen; P Kuusanmäki; E Savilahti; P Vento; T Paavonen; J Halttunen
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

4.  CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking.

Authors:  G R Yeaman; J E Collins; M W Fanger; C R Wira; P M Lydyard
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

Review 5.  Estrogen responsiveness and control of normal human breast proliferation.

Authors:  E Anderson; R B Clarke; A Howell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

6.  The enhanced peroxidase one step method increases sensitivity for detection of Ki-67 in pituitary tumours.

Authors:  H E Turner; Z Nagy; M M Esiri; J A Wass
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

7.  Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.

Authors:  S N Andersen; T O Rognum; A Bakka; O P Clausen
Journal:  Mol Pathol       Date:  1998-12

8.  Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

Authors:  S S Case; M A Price; C T Jordan; X J Yu; L Wang; G Bauer; D L Haas; D Xu; R Stripecke; L Naldini; D B Kohn; G M Crooks
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  Circadian variation in the expression of cell-cycle proteins in human oral epithelium.

Authors:  G A Bjarnason; R C Jordan; R B Sothern
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

10.  IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients.

Authors:  N Azimi; M Nagai; S Jacobson; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.